Discover the power of Ultromics EchoGo Core SaaS. The first & only system of its kind to fully automate cardiac analysis with zero variability & zero operation required. (3)
Discover how Automated Echocardiographic Detection of Heart Failure With Preserved Ejection Fraction Using Artificial Intelligence explores the latest research on AI-based Echo Diagnostics
Discover how Association Of A Novel, Non-Invasive AI Model To Automate Echocardiographic Detection Of Heart Failure With Preserved Ejection Failure (HFpEF) With Invasive Hemodynamics explores the latest research on AI-based Echo Diagnostics.
Discover now Automated Echocardiographic Detection of Heart Failure With Preserved Ejection Fraction Using Artificial Intelligence. Explore the latest research on AI-based Echo Diagnostics.
Discover the 2023 HFSA Study Poster -Clinical Utility of An AI-Based Model For Detection of Heart Failure With Preserved Ejection Fraction Using Decision Curve Analysis
Discover the Jacc Advances paper - Automated Detection of HFpEF using AI
Discover how Novel Deep Learning Model For The Detection Of Cardiac Amyloidosis, A Pilot Reader Study explores the latest research on AI-based Echo Diagnostics.
Discover how Automated Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction using Artificial Intelligence explores the latest research on AI-based Echo Diagnostics.
Discover how Comparison Of Clinical Algorithms And AI Applied To An Echocardiogram To Categorize Risk Of HFpEF explores the latest research on AI-based Echo Diagnostics.
In this Cleveland clinic study, EchoGo demonstrated that it can play a role in the risk stratification of hospitalized COVID-19 patients.
This international study aims to determine the clinical and echocardiographic phenotype of acute cardiac disease in COVID-19 patients, using EchoGo Core.
Sign-up to hear about the latest news.
Sign up to newsletter
cases processed